Mario Sideri

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine.

Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine.

Journal: Journal of lower genital tract disease

Published: October 19, 2016

HPV self-sampling in CIN2+ detection: sensitivity and specificity of different RLU cut-off of HC2 in specimens from 786 women.

HPV self-sampling in CIN2+ detection: sensitivity and specificity of different RLU cut-off of HC2 in specimens from 786 women.

Journal: Journal of clinical pathology

Published: July 22, 2016

Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity.

Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity.

Journal: Archives of gynecology and obstetrics

Published: March 14, 2016

hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi).

hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi).

Journal: Epidemiologia e prevenzione

Published: September 26, 2015

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions.

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions.

Journal: Journal of Cancer

Published: August 08, 2015

Evaluating HPV-negative CIN2+ in the ATHENA trial.

Evaluating HPV-negative CIN2+ in the ATHENA trial.

Journal: International journal of cancer

Published: July 15, 2015

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples.

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples.

Journal: Papillomavirus research (Amsterdam, Netherlands)

Published: June 04, 2015

LAST terminology applied to the vulva: the challenge of VIN continues.

LAST terminology applied to the vulva: the challenge of VIN continues.

Journal: Journal of lower genital tract disease

Published: March 27, 2015

Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.

Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.

Journal: Cancer cytopathology

Published: January 31, 2015

Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions.

Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions.

Journal: Journal of clinical microbiology

Published: January 30, 2015

Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.

Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.

Journal: British journal of cancer

Published: December 19, 2014

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections.

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections.

Journal: Ecancermedicalscience

Published: November 13, 2014

Showing 1-12 of 37

Last Updated: 09/26/2026